Reference numberEC/1943/05
Previous numbersCert XV, 53; A02299
TitleEwins, Arthur James: certificate of election to the Royal Society
CitationResearch Chemist (Industrial). Distinguished for chemical researches in connexion with pharmaceutical industry. From 1904-1914 published from the Wellcome Research Laboratories, in collaboration or alone, in important researches on alkaloids (ergot, laburnum, etc), amines from aminoacids, choline esters; first isolated acetylcholine from a natural source, identified 'artificial muscarine' as nitrosocholine. Since 1915, as research chemist and director of research to May & Barker Ltd., has produced many new synthetic remedies, including some of the most important in recent years - 'M & B 693' (pyridylsupphanilamide) used in pneumonia, meningitis etc, and a new series of aromatic diamidines, of great promise in several important tropical diseases.
ProposersH H Dale; Harold King; Warrington Yorke; Percival Hartley; C H Andrewes; E Mellanby; R Robinson; C M Wenyon; Gordon Holmes
Access statusOpen

Ewins, Arthur James: certificate of election to the Royal Society

Fellows associated with this archive
NA2236Ewins; Arthur James (1882 - 1957)1882 - 1957
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView


    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →


    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView